Intelligent Bio Solutions Targets Global Markets with Multilingual Digital Expansion
Medical technology company Intelligent Bio Solutions is launching Arabic, Italian, and Spanish websites to support international growth, targeting over 1.4 billion potential customers across Latin America, the Middle East, and Southern Europe.
Intelligent Bio Solutions (NASDAQ: INBS) is accelerating its global commercial strategy by introducing multilingual digital platforms in Arabic, Italian, and Spanish. The medical technology company aims to remove communication barriers and expand its market reach in key international regions.
The new websites will support the company's non-invasive workplace drug testing technology, which is currently deployed by over 450 clients across 24 countries. By creating digital access in these languages, INBS can potentially engage with markets representing 1.4 billion people across Latin America, the Middle East, and Southern Europe.
The strategic digital rollout aligns with increasing global demand for innovative workplace safety and compliance solutions. INBS's flagship product—a fingerprint sweat-based drug screening system—positions the company to capitalize on growing international interest in non-invasive testing technologies.
With plans for a U.S. market launch in 2025 and ongoing development of additional biosensor applications, the multilingual website initiative represents a significant step in INBS's international expansion strategy. By providing localized digital experiences, the company can more effectively communicate its technological capabilities and market potential to diverse global audiences.